Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Hematology/Oncology and Stem Cell Therapy
|
April 5, 2011
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma
Jean El Cheikh, Elias Kfoury, Boris Calmels, et al.
Bone Marrow Transplantation
|
September 20, 2019
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation
Charlotte Nykolyszyn, Angela Granata, Thomas Pagliardini, et al.
American Journal of Hematology
|
March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 8, 2018
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
Thomas Pagliardini, Samia Harbi, Sabine Fürst, et al.
Bone Marrow Transplantation
|
March 15, 2024
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease
Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, et al.
Experimental Hematology
|
March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 6, 2010
Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children
Vincent Barlogis, Laurence Glasman, Corine Brunet, et al.
Clinical Epigenetics
|
October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
Sylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation
Raynier Devillier, Samia Harbi, Sabine Fürst, et al.
Experimental Hematology
|
September 21, 2010
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies
Didier Blaise, Laure Farnault, Catherine Faucher, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Hematology/Oncology and Stem Cell Therapy
|
April 5, 2011
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma
Jean El Cheikh, Elias Kfoury, Boris Calmels, et al.
Bone Marrow Transplantation
|
September 20, 2019
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation
Charlotte Nykolyszyn, Angela Granata, Thomas Pagliardini, et al.
American Journal of Hematology
|
March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 8, 2018
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
Thomas Pagliardini, Samia Harbi, Sabine Fürst, et al.
Bone Marrow Transplantation
|
March 15, 2024
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease
Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, et al.
Experimental Hematology
|
March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 6, 2010
Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children
Vincent Barlogis, Laurence Glasman, Corine Brunet, et al.
Clinical Epigenetics
|
October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation
Sylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation
Raynier Devillier, Samia Harbi, Sabine Fürst, et al.
Experimental Hematology
|
September 21, 2010
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies
Didier Blaise, Laure Farnault, Catherine Faucher, et al.
Page
of 7